Will Corcept (CORT) Beat Estimates Again in Its Next Earnings Report?
cept Therapeutics rporated(CORT) Zacks Investment Research·2024-01-30 02:11Corcept Therapeutics (CORT) 盈利表现 - 过去两个季度，Corcept Therapeutics 属于 Zacks Medical - Drugs 行业，持续超过盈利预期[1],[2] - 上个季度，Corcept 的盈利为每股 $0.28，超过了 Zacks 预期的 $0.22，达到了 27.27% 的惊喜[3] - Corcept 目前的盈利预期呈现积极态势，Zacks Earnings ESP 为正值，结合其稳健的 Zacks Rank，预示着可能会再次超过盈利预期[4],[7]